Tuesday, November 5, 2024
HomeTagsAscending dose design

ascending dose design

Argus Research Initiates Equity Report Coverage on ProMIS Neurosciences, Inc. (TSX:PMN & OTCQB: ARFXF)

Argus Research, an independent investment research firm, has launched Argus Equity Report coverage on ProMIS Neurosciences, Inc. Click here to view Full Argus Equity Report Excerpts...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics